Exploration · 2023 · 32 citations · 54 references
MedicineMedicinal ChemistryPharmacologyDiabetologyDrug DiscoveryMolecular PharmacologyCannabinoid PharmacologyDiabetes MellitusDiabetes PharmacotherapyDiabetic NeuropathyDiabetic RetinopathyInsulin ResistanceCannabinoid AgonistsCannabinoid Structure-activity RelationshipsImpaired Kidney FunctionPharmacological Therapy
In recent years, cannabidiol (CBD), a non-psychotropic cannabinoid, has garnered substantial interest in drug development due to its broad pharmacological activity and multi-target effects. Diabetes is a chronic metabolic disease that can damage multiple organs in the body, leading to the development of complications such as abnormal kidney function, vision loss, neuropathy, and cardiovascular disease. CBD has demonstrated significant therapeutic potential in treating diabetes mellitus and its complications owing to its various pharmacological effects. This work summarizes the role of CBD in diabetes and its impact on complications such as cardiovascular dysfunction, nephropathy, retinopathy, and neuropathy. Strategies for discovering molecular targets for CBD in the treatment of diabetes and its complications are also proposed. Moreover, ways to optimize the structure of CBD based on known targets to generate new CBD analogues are explored.
54
Executive Summary: Heart Disease and Stroke Statistics—2016 Update
Dariush Mozaffarian, Emelia J. Benjamin, Alan S. Go et al. · Circulation · 2016 · 2.5K citations
Mohanraj Rajesh, Partha Mukhopadhyay, Sándor Bátkai et al. · Journal of the American College of Cardiology · 2010 · 490 citations · Full text
Medicine, Cardiology, Pharmacology +17
Mitsugu Yamanaka, Taizo Ishikawa, Angelika Griep et al. · Journal of Neuroscience · 2012 · 328 citations · Full text